SenoRx was founded in 1998 to design, develop, manufacture and market minimally invasive devices for the diagnosis and treatment of breast cancer. We place a high priority on outstanding customer service and on maintaining and growing a strong portfolio of intellectual property. Our goal is to become the leader in our industry by offering products and procedures that dramatically enhance patient outcomes.

Now part of Bard Biopsy Systems, together we bring Choice Without Compromise in products and service providing Breast Care Solutions from Biopsy to Therapy.